Chassatide C2A

General Information


DRACP ID  DRACP00398

Peptide Name   Chassatide C2A

Sequence  GIPCAESCVWIPCTITALXGCSCKNNVCYNN

Sequence Length  31

UniProt ID  I0B6F2 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50>15 μM MTT assay Not available 1

Hemolytic Activity  Human erythrocytes: HD50>25 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys4<--->Cys21; Cys8<--->Cys23; Cys13<--->Cys28; NCB: Gly1<--->Asn31

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=MetO (Methionine sulfoxide)

Chiral  L



Physicochemical Information


Formula  C133H208N36O41S6

Absent amino acids  DFHMQR

Common amino acids  C

Mass  380500

Pl  5.94

Basic residues  1

Acidic residues  1

Hydrophobic residues  9

Net charge  0

Boman Index  -773

Hydrophobicity  44.19

Aliphatic Index  75.48

Half Life 
  /

Extinction Coefficient cystines  7365

Absorbance 280nm  245.5

Polar residues  17

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22467870

Title  Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities

Doi 10.1074/jbc.M111.338970

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4284

DRACP is developed by Dr.Zheng's team.